Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026
Businesswire·2026-02-06 13:32
Core Viewpoint - Niagen Bioscience, Inc. (NASDAQ: NAGE) is set to hold a conference call on March 4, 2026, to discuss its financial results for Q4 and fiscal year 2025, which ended on December 31, 2025 [1]. Financial Results Announcement - The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call [1].